Journal article

Publication year: 2013

Pages: 1131-1139

Journal: The Journal of Heart and Lung Transplantation

Volume number: 32

Issue number: 11

ISSN: 1053-2498

eISSN: 1557-3117

DOI Link: https://doi.org/10.1016/j.healun.2013.07.016

Publisher: Elsevier

Abstract: 

BACKGROUND: The long-term success of human lung transplantation is limited by the development of bronchiolitis obliterans syndrome. Acute rejection episodes and infections are important risk factors and seem to play major pathogenic roles. We established a relevant experimental model that mimics important aspects of human bronchiolitis obliterans syndrome.

METHODS: The Fischer 344-to-Lewis rat strain combination was used for orthotopic left lung transplantation. Isogeneic transplantations were performed in the Lewis rat. Recipients were treated with ciclosporin for 10 days. Lipopolysaccharide or vehicle was instilled into the airways 28 days after transplantation. Grafts were monitored by computed tomography, and recipients were euthanized on Days 28-90. The messenger RNA expression of selected chemokines and their receptors was measured on Days 28, 29, 33, 40 after transplantation. Graft histopathology on Day 90 was compared with lungs from patients who underwent re-transplantation due to end-stage allograft dysfunction.

RESULTS: Lung allografts treated with ciclosporin and vehicle only sporadically displayed tissue remodeling. In contrast, lipopolysaccharide treatment induced severe inflammation. In the long-term, severe vascular remodeling, lung fibrosis, and fibroproliferative remodeling of airways were found that closely resemble the histopathologic changes in grafts from human patients with bronchiolitis obliterans syndrome. Chronic damage was virtually absent from pulmonary isografts and native right lungs. Chemokine (C-C motif) ligand 5 and chemokine (C-X-C motif) ligand 9-11, and their receptors, were over-expressed in allografts.

CONCLUSIONS: Our experimental model mirrors key aspects of human bronchiolitis obliterans syndrome. It will be useful to elucidate its pathogenesis and to develop therapeutic approaches improving the long-term outcome of human lung transplantation. (C) 2013 International Society for Heart and Lung Transplantation. All rights reserved.

Harvard Citation style: Atanasova, S., Hirschburger, M., Jonigk, D., Obert, M., Petri, K., Evers, A., et al. (2013) A relevant experimental model for human bronchiolitis obliterans syndrome, The Journal of Heart and Lung Transplantation, 32(11), pp. 1131-1139. https://doi.org/10.1016/j.healun.2013.07.016

APA Citation style: Atanasova, S., Hirschburger, M., Jonigk, D., Obert, M., Petri, K., Evers, A., Hecker, A., Schmitz, J., Kaufmann, A., Wilhelm, J., Chakraborty, T., Warnecke, G., Gottlieb, J., Padberg, W., & Grau, V. (2013). A relevant experimental model for human bronchiolitis obliterans syndrome. The Journal of Heart and Lung Transplantation. 32(11), 1131-1139. https://doi.org/10.1016/j.healun.2013.07.016